company background image
STTK

Shattuck Labs NasdaqGS:STTK Stock Report

Last Price

US$2.18

Market Cap

US$92.4m

7D

9.0%

1Y

-74.3%

Updated

29 Nov, 2022

Data

Company Financials +
STTK fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

STTK Stock Overview

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States.

Shattuck Labs, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shattuck Labs
Historical stock prices
Current Share PriceUS$2.18
52 Week HighUS$9.61
52 Week LowUS$1.85
Beta0.95
1 Month Change-17.89%
3 Month Change-32.92%
1 Year Change-74.29%
3 Year Changen/a
5 Year Changen/a
Change since IPO-88.73%

Recent News & Updates

Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Invest In Growth?

Nov 23
Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Invest In Growth?

Recent updates

Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Invest In Growth?

Nov 23
Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Invest In Growth?

We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate

Jul 26
We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate

Shattuck Labs, Inc. (NASDAQ:STTK) Just Reported And Analysts Have Been Cutting Their Estimates

Mar 18
Shattuck Labs, Inc. (NASDAQ:STTK) Just Reported And Analysts Have Been Cutting Their Estimates

Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Deliver On Growth Plans?

Feb 25
Is Shattuck Labs (NASDAQ:STTK) In A Good Position To Deliver On Growth Plans?

Will Shattuck Labs (NASDAQ:STTK) Spend Its Cash Wisely?

Nov 23
Will Shattuck Labs (NASDAQ:STTK) Spend Its Cash Wisely?

We Think Shattuck Labs (NASDAQ:STTK) Can Afford To Drive Business Growth

Aug 24
We Think Shattuck Labs (NASDAQ:STTK) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation

May 07
Here's Why We're Not Too Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation

Could The Shattuck Labs, Inc. (NASDAQ:STTK) Ownership Structure Tell Us Something Useful?

Mar 08
Could The Shattuck Labs, Inc. (NASDAQ:STTK) Ownership Structure Tell Us Something Useful?

We're Hopeful That Shattuck Labs (NASDAQ:STTK) Will Use Its Cash Wisely

Jan 12
We're Hopeful That Shattuck Labs (NASDAQ:STTK) Will Use Its Cash Wisely

Shareholder Returns

STTKUS BiotechsUS Market
7D9.0%-1.0%-0.9%
1Y-74.3%-15.2%-18.9%

Return vs Industry: STTK underperformed the US Biotechs industry which returned -16.1% over the past year.

Return vs Market: STTK underperformed the US Market which returned -20.5% over the past year.

Price Volatility

Is STTK's price volatile compared to industry and market?
STTK volatility
STTK Average Weekly Movement11.3%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: STTK is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: STTK's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
201685Taylor Schreiberhttps://www.shattucklabs.com

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company’s lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma.

Shattuck Labs, Inc. Fundamentals Summary

How do Shattuck Labs's earnings and revenue compare to its market cap?
STTK fundamental statistics
Market CapUS$92.41m
Earnings (TTM)-US$68.69m
Revenue (TTM)US$30.34m

3.0x

P/S Ratio

-1.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
STTK income statement (TTM)
RevenueUS$30.34m
Cost of RevenueUS$77.22m
Gross Profit-US$46.88m
Other ExpensesUS$21.81m
Earnings-US$68.69m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.62
Gross Margin-154.51%
Net Profit Margin-226.39%
Debt/Equity Ratio0%

How did STTK perform over the long term?

See historical performance and comparison